There is a need for a large-animal model to investigate the etiology and biology of cystic fibrosis (CF) lung disease and to study potential therapies. The 
degree of similarity is 95% (compared with 88% between human and mouse). Northern blot analysis and reverse transcription-PCR have shown that the patterns of expression of the ovine CFTR gene are very similar to those seen in humans. Further, the developmental expression of CFTR in the sheep is equivalent to that observed in humans. Thus, overall a CF sheep should show lung pathology similar to that of humans with CF.
The autosomal recessive disease cystic fibrosis (CF), which is characterized by severe lung disease, digestive problems, male infertility, and an elevated sweat chloride ion concentration, is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene (1, 2) . The CFTR protein codes for a small conductance chloride ion channel (3-7), although judging from its homology with members of the ABC transporter superfamily (8) , it may have one or more, as yet unknown, additional functions. Despite this incomplete understanding of the function of the CFTR gene and its protein product, substantial progress has been made toward devising strategies for CF gene therapy. In the absence of a naturally occurring animal model for CF, four lines of transgenic CF mice have been generated. Each of these carries a different mutation: one contains an insertion mutation (9) , two have disruptions within exon 10 of the mouse gene (10) (11) (12) , and one has a targeted disruption of exon 3 (13) . All transgenic CF mice show some pathological features that are reminiscent of the pathology of CF in humans; however, the respiratory system and pancreatic ducts are minimally affected. In general, the mice show severe intestinal disease, and it is this aspect of the pathology that proves lethal, rather than the lung disease that is usually responsible for death in humans with CF. This is possibly due to anatomical and physiological differences in the human and mouse lung, including the presence in some epithelia of alternative routes for chloride secretion (14, 15) .
Lung epithelium in transgenic CF mice does show electrophysiological differences from normal mouse lung epithelium, and it appears possible to correct these electrophysiological differences by gene therapy (16, 17) . Treatment of CF lung disease may also benefit from pharmacological approaches to treatment; however, due to species differences, particularly in body size and lung anatomy, it may not be possible to test these treatments effectively on mice.
Another aspect of the CF disease process that may not be adequately addressed by the CF mouse model is the developmental expression of the disease. It has been shown that the CFTR gene is expressed early in human development (18, 19) , and this correlates temporally with the development of CF pathology, particularly in the pancreas. Importantly, CFTR mRNA, which is expressed at low levels in adult respiratory epithelium, is present at substantial levels throughout the respiratory epithelium prior to birth.
A large animal model of CF would be a great advantage in investigating the significance of the developmental expression of CFTR and furthering pharmacological approaches to the treatment of CF lung disease. Such an animal would be sufficiently large to allow bronchoscopy and survive lung biopsy and suitably long-lived to allow treatment to be followed for up to a decade. The sheep is an ideal potential model for CF study, as its lung has been well studied from both electrophysiological and developmental aspects and shows close similarities to the human lung, particularly with respect to the function of the respiratory epithelium (20, 21) . We tTo whom reprint requests should be addressed. §The sequence reported in this paper has been deposited in the GenBank data base (accession no. U20418).
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Reverse Transcription-PCR (RT-PCR). Specific fragments of the ovine CFTR cDNA were amplified either from lymphocyte poly(A)+ RNA or from midfetal tissue total RNA by the method of Chalkley and Harris (24) , which has been shown to detect the functional CFTR sequence in humans. The primer sequences are shown in Table 1 . For the PCR reaction, an initial 5-min denaturation step at 94°C was followed by 30 cycles of 1 min at 94°C (denaturation), 1 min at 60°C (annealing), and 4-7 min at 72°C (extension using AmpliTaq; PerkinElmer), the time depending on the length of the cDNA fragment. After the 30 cycles, a final polymerization step was carried out at 72°C for 5 min. For amplification from lymphocyte RNA, two rounds of PCR were required. A total of 1 ,ul of the first PCR reaction mixture was transferred to 49 ,ul of a PCR buffer mixture containing 500 ng of each primer in the nested set. An additional 30 cycles of amplification were performed by using the same parameters as for the first reaction.
For RT-PCR analysis of CFTR gene expression, a 530-bp fragment of the expressed P1 housekeeping gene encoding subunit c of sheep mitochondrial ATP synthase (25) was coamplified with fragment C (792 bp) of the ovine CFTR mRNA by using RT-PCR on total RNA. The primers homologous to the Pl housekeeping gene were at 1/10th the concentration of those for CFTR. The specific fragments generated by each PCR were verified by restriction enzyme digestion and direct sequencing. All primer sets were shown not to amplify a specific product from genomic DNA.
Cloning and Sequencing of the Ovine CF17R cDNA Fragments. PCR products were isolated by using a Geneclean II kit (Stratech, London). Purified PCR product (100-200 ng) was subjected to direct sequence analysis (26) by using deoxyade-
DNA polymerase (United States Biochemical), and an appropriate oligonucleotide primer to verify the product as CFTR. Another aliquot of the PCR product was then inserted into the pCRII vector by using the TA Cloning System (Invitrogen). DNA sequencing was carried out by using the dideoxynucleotide chain-termination method of Sanger et al. (27) as adapted for double-stranded templates by Murphy and Kavanagh (28) . Templates were primed by using the M13 forward and reverse primer oligonucleotides. DNA sequence information was assembled and analyzed by using computer software (29, 30) . Three independent RT-PCR clones were characterized for each ovine CFTR cDNA fragment. All DNA sequence information was obtained from both strands.
Northern Analysis. Total RNA (20 
RESULTS AND DISCUSSION
Cloning and Sequencing the Ovine CFUR cDNA. Nested RT-PCR was used to amplify specific regions A-F of the ovine CFTR cDNA, which broadly correspond to functional domains of the CFTR protein, from sheep blood lymphocyte poly(A)+ RNA by the methodology of Chalkley and Harris (24) . Amplified DNA fragments were gel purified and directly sequenced to confirm their CFTR identity before being inserted into the pCRII vector. The specific regions A, B, C, D', Table 1 ). Three independent RT-PCR amplified clones from each of the a, A, B, C, D', F, and G regions were sequenced and characterized. Sequence discrepancies among the three clones were interpreted mainly as Taq polymerase-induced errors, given that Taq polymerase lacks proofreading ability and is prone to introduce nucleotide base errors that are amplified as PCR proceeds (33) . All sequence discrepancies were eliminated by direct sequence analysis of genomic DNA.
The consensus sequence from each of the seven fragments was ordered and assembled into the overall ovine CFTR cDNA sequence [GenBank accession no. U20418 (OVCFTRC)]. The spatial relationships among the seven fragments, as well as the location of the functional domains of the CFTR polypeptide, are represented schematically in Fig. 1 . The predicted 1481-amino acid sequence of the ovine CFTlR protein is shown in Fig. 2 The R domain shows the lowest level of homology: the amino acid sequence identity between human and sheep is 83% (88.8% similarity), in agreement with the idea that the functional requirements for the R domain are not linked to absolutely conserved primary structure (32) . Even so, within the R domain, short regions of conserved amino acid sequences are present and may represent important functional sites.
Expression of Ovine CVTR mRNA. To study the pattern of CFTR expression in the sheep, two different approaches were employed: RT-PCR and Northern analysis of total RNA.
RT-PCR. RT-PCR was used to selectively search total RNA from different fetal and adult sheep tissues for two independent gene transcripts. One set of primers would amplify the C fragment of the ovine CFTR message, while another set amplified the transcript encoding the c subunit of ovine ATP synthase (25) and acted as an internal control in the experiment. Detection of the CFTR and ATP synthase transcripts in different tissues at different developmental stages is shown in Fig. 3 . Each lane shows the RT-PCR product from 1 ,ug of total RNA. The larger RT-PCR product (792 bp) is specific for CFTR and the smaller product (530 bp) represents the ATP synthase subunit c control housekeeping transcript. As it is a housekeeping gene, it is likely that the ATP synthase subunit c gene is expressed at equivalent levels in each tissue analyzed. In the adult sheep, CFTR is expressed at relatively high levels in duodenum, distal ileum, and liver; possibly at intermediate levels in the lung and colon; at lower levels in the trachea; and is not expressed in skeletal muscle. In late-fetal life, CFTR is highly expressed in duodenum, distal ileum, colon, pancreas, gall bladder, and liver; expressed at lower levels in lung and testis; expressed at very low levels in kidney, ovary, and thymus; and expressed at barely detectable levels in skeletal muscle. In midfetal life, CFTR is expressed at high levels in duodenum, cecum, colon, and gall bladder; at intermediate . 792 bp * 530 bp levels in trachea, lung, distal ileum, pancreas, liver, and thymus; at low levels in kidney, testis, and cardiac muscle; and at barely detectable levels in skeletal muscle.
Northern Analysis. Semiquantitative data on the level of CFTR expressed in different tissues at different stages of development were obtained by Northern analysis of total RNA samples from sheep tissue by using an ovine CFTR D' fragment probe. Fig. 4 shows the results, including a representation of the relative loading levels of RNA for each sample, revealing CFTR to be expressed in a tissue-specific and developmental-specific manner. Table 2 Fig. 3 . mf, Mid-fetal; lf, late fetal; ad, adult.
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Proc. Nati Acad Sci. USA 92 (1995) 2297 (18, 19) ; however, expression in the newborn and adult human respiratory epithelium is at very low levels compared to that in the fetal lung (19, 38) . Likewise, our data indicate much greater CFTR expression in the lungs of fetal sheep than of adult sheep. Moreover, expression of CFTR in fetal sheep lung and gastrointestinal tracts is at high levels at least by 70 days of the 148-day gestation period, a point equivalent to an 18-week human fetus.
In summary, we have shown that the spatial and developmental expression of CFTR in the sheep is similar to that seen in the human. Therefore, the sheep lung may provide a useful system in which to reproduce CF lung disease. The cloning and subsequent sequencing of the ovine CFTR cDNA has provided the necessary information to embark on a genetic screening program to look for natural CFTR variants in sheep populations. Several putative polymorphisms have been identified thus far. To investigate the lung pathology in CF further, natural variants of sheep with CFTR mutations that lead to CF can be selected and bred to produce a line of animals with a CF lung disease phenotype.
